| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.004 | 16.407 | 12.820 | 17.576 | 16.498 | 8.562 | 8.707 | 11.037 | 16.279 | 11.768 |
| Total Income - EUR | 15.004 | 16.407 | 12.820 | 17.576 | 16.814 | 8.562 | 8.707 | 11.037 | 16.279 | 11.768 |
| Total Expenses - EUR | 8.754 | 7.608 | 5.895 | 13.533 | 13.503 | 7.526 | 6.217 | 7.844 | 13.649 | 7.654 |
| Gross Profit/Loss - EUR | 6.250 | 8.799 | 6.925 | 4.043 | 3.311 | 1.036 | 2.490 | 3.192 | 2.630 | 4.114 |
| Net Profit/Loss - EUR | 5.800 | 8.347 | 6.540 | 3.868 | 3.083 | 904 | 2.446 | 2.993 | 2.290 | 3.535 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Daviprim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 4.626 | 2.481 | 60 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 8.470 | 16.761 | 13.282 | 19.480 | 24.574 | 24.948 | 27.054 | 26.111 | 3.408 | 6.897 |
| Inventories | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 316 | 310 | 0 | 0 | 0 | 35 |
| Cash | 8.470 | 16.760 | 13.281 | 19.479 | 24.257 | 24.638 | 27.054 | 26.111 | 3.408 | 6.862 |
| Shareholders Funds | 8.295 | 16.558 | 18.221 | 21.754 | 24.416 | 24.857 | 26.918 | 25.939 | 3.163 | 6.681 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 175 | 203 | -313 | 207 | 219 | 90 | 136 | 171 | 245 | 217 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Daviprim Srl